GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

School of Pharmacy & Technology Management, SVKM’S NMIMS Deemed-to-be University, Shirpur, Maharashtra 425405, India ...

Chris Cabell, MD MHS FACC Appointed President and Head of Research & Development ------ John Adams, PhD Appointed Chief Scientific ...

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.

Mr. Iwicki Brings Track Record of Operational Excellence and Significant Expertise in PAH and Cardiovascular Diseases ---- Amit Munshi ...

Inhibikase Therapeutics, Inc.’s IKT share price has surged by 18.46%, which has investors questioning if this is right time ...

Chen, D. and Li, L. (2025) Huge Pelvic GIST Got Good Control after Resistance to Tyrosine Kinase Inhibitors by SIB-IMRT: A ...

Dr. Carlos Correa discusses the impact of evergreening strategies on access to generic and biosimilar medicines globally.

Out-of-pocket costs like deductibles and copays deter people with cancer from complying with treatment.This creates a ...

Gene-editing specialist Editas Medicine has halted development of its lead clinical programme for congenital eye disorders after it generated lacklustre results in a phase 1/2 trial. The ...